Costo-efectividad de añadir el péptido natriurético tipo B al índice de LEE en la evaluación del riesgo cardiovascular en cirugía mayor no cardiaca

Mario García Molina, Liliana Chicaíza and Oscar Gamboa

Econógrafos, Escuela de Economía from Universidad Nacional de Colombia, FCE, CID

Abstract: A decision tree is used to assess the cost effectiveness of adding the type B natriuretic peptid to the revised Lee index of cardiovascular risk. The Lee=3 strategy is cost effective for a WTP lower than Col $11.292.903 at a cost per patient of Col $79.452. Lee strategy with a threshold of 3 has the best profile of cost effectiveness, but the results were very sensitive to the probability of cardio vascular events.

Keywords: Health Economics; Encefalic natriuretic peptid; Risk; Cardio-vascular diseases; Cost benefit analysis (search for similar items in EconPapers)
JEL-codes: D61 I11 (search for similar items in EconPapers)
Pages: 14
Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://fce.unal.edu.co/media/files/CentroEditoria ... ntos-economia-20.pdf

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:col:000176:022985

Access Statistics for this paper

More papers in Econógrafos, Escuela de Economía from Universidad Nacional de Colombia, FCE, CID Contact information at EDIRC.
Bibliographic data for series maintained by Facultad de Ciencias Económicas Unal ().